Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium Carbonate in Low-Grade Neuroendocrine Tumors
NCT00501540Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Jul 2007
- Primary completion
- Jun 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lithium carbonate in neuroendocrine tumors (NETs), sponsored by University of Wisconsin–Madison. Started Jul 2007; status: completed.
02
Drugs
lithium carbonate
03
Conditions
neuroendocrine tumors (NETs)
Beyond the preview
Go deeper on NCT00501540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501540.